<DOC>
	<DOCNO>NCT00391833</DOCNO>
	<brief_summary>We investigate clinical efficacy Panax ginseng Alzheimer ’ disease ( AD ) .</brief_summary>
	<brief_title>Effect Panax Ginseng Cognitive Performance Alzheimer ’ Disease</brief_title>
	<detailed_description>Alzheimer ’ disease ( AD ) characterize progressive decline memory intellectual ability , interfere activity daily living , overall quality life , ultimately lead death . Although pharmacologic treatment currently approve treat mild- moderate AD use acetylcholinesterase inhibitor ( ACEI ) memantine , NMDA antagonist , advanced stage AD , therapeutic efficacy need improve . For millennium , ginseng component use treat medical condition , pharmacologic effect demonstrate cardiovascular , endocrine immune system ( Attele et al. , 1999 ) . In means memory learning , number study suggest ginseng attenuate learn deficit damage age brain rodent model ( Kennedy et al. , 2003 ; Zhao McDaniel , 1998 ; Nitta et al. , 1995 ) . In study human healthy participant , correspondently , acute chronic dosage ginseng increase cognitive performance ( Kennedy et al. , 2001 ; Kennedy et al. , 2003 ; D ’ Angelo et al. , 1986 ; Sorensen Sonne , 1996 ) . In study , investigate contribution ginseng treatment increase cognitive improvement AD patient . In addition , test various bio-markers hematopoietic progenitor cell count include patient use blood sample . Patients AD well memory decline include</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Alzheimer 's disease neurologic disease</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>83 Years</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>Alzheimer 's disease , Ginseng , CD34</keyword>
</DOC>